Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella

被引:94
作者
Miriagou, V
Tassios, PT
Legakis, NJ
Tzouvelekis, LS [1 ]
机构
[1] Hellenic Pasteur Inst, Bacteriol Lab, Athens, Greece
[2] Univ Athens, Sch Med, Dept Microbiol, Athens 11527, Greece
关键词
Salmonella; resistance; cephalosporin;
D O I
10.1016/j.ijantimicag.2004.03.006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Expanded-spectrum cephalosporins (ESCs) such as ceftriaxone, together with fluorinated quinolones, are the choice antibiotics in the treatment of invasive salmonella infections. Resistance to ESCs among non-typhoid salmonella has been recognised since the late 1980s. Currently, ESC-resistant salmonella strains are reported world-wide and in some areas their incidence is significant. Resistance is mainly due to acquisition of multi-resistant plasmids encoding a variety of extended- spectrum and AmpC-type beta-lactamases. The origins of ESC-resistant salmonellae are diverse. Exchange of resistance determinants between salmonellae and nosocomial enterobacteria seems to be frequent, at least in developing countries. Also, the use of newer beta-lactams in animal husbandry and veterinary medicine may have facilitated the spread of ESC-resistant salmonella strains in livestock. (C) 2004 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:547 / 555
页数:9
相关论文
共 86 条
[51]   Characterization of the first extended-spectrum beta-lactamase-producing Salmonella isolate identified in Canada [J].
Mulvey, MR ;
Soule, G ;
Boyd, D ;
Demczuk, W ;
Ahmed, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (01) :460-462
[52]   Antimicrobial resistance in Salmonella enteritidis, southern Italy, 1990-1998 [J].
Nastasi, A ;
Mammina, C ;
Cannova, L .
EMERGING INFECTIOUS DISEASES, 2000, 6 (04) :401-403
[53]   CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000) [J].
Navarro, F ;
Perez-Trallero, E ;
Marimon, JM ;
Aliaga, R ;
Gomariz, M ;
Mirelis, B .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (03) :383-389
[54]   Evolution of multiresistance in nontyphoid Salmonella serovars from 1984 to 1998 in Argentina [J].
Orman, BE ;
Piñeiro, SA ;
Arduino, S ;
Galas, M ;
Melano, R ;
Caffer, MI ;
Sordelli, DO ;
Centrón, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (12) :3963-3970
[55]   Antibiotic resistance patterns and plasmid profiles of Salmonella typhimurium isolates in Turkey [J].
Otkun, M ;
Erdem, B ;
Akata, F ;
Tatman-Otkun, M ;
Gerceker, D ;
Yagci, S ;
Ozkan, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (03) :206-209
[56]   Antibiotic susceptibility and genotypes of non-typhi Salmonella isolates from children in Kilifi on the Kenya coast [J].
Oundo, JO ;
Kariuki, S ;
Maghenda, JK ;
Lowe, BS .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2000, 94 (02) :212-215
[57]   Infection due to extended-spectrum β-lactamase-producing Salmonella enterica subsp enterica serotype Infantis in a neonatal unit [J].
Pessoa-Silva, CL ;
Toscano, CM ;
Moreira, BM ;
Santos, AL ;
Frota, ACC ;
Solari, CA ;
Amorim, ELT ;
Carvalho, MDS ;
Teixeira, LM ;
Jarvis, WR .
JOURNAL OF PEDIATRICS, 2002, 141 (03) :381-387
[58]   Plasmid-determined AmpC-type β-lactamases [J].
Philippon, A ;
Arlet, G ;
Jacoby, GA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) :1-11
[59]  
Piddock LJV, 2002, FEMS MICROBIOL REV, V26, P3, DOI [10.1111/j.1574-6976.2002.tb00596.x, 10.1016/S0168-6445(01)00076-6]
[60]   Association between handling of pet treats and infection with Salmonella enterica serotype Newport expressing the AmpC β-lactamase, CMY-2 [J].
Pitout, JDD ;
Reisbig, MD ;
Mulvey, M ;
Chui, L ;
Louie, M ;
Crowe, L ;
Church, DL ;
Elsayed, S ;
Gregson, D ;
Ahmed, R ;
Tilley, P ;
Hanson, ND .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (10) :4578-4582